India  
 
NewsR.in

Novavax COVID-19 Vaccine Candidate 96.4% Effective In U.K. Trial, Company Says

Video Credit: WJZ Baltimore - Duration: 00:24s - Published
Novavax COVID-19 Vaccine Candidate 96.4% Effective In U.K. Trial, Company Says

Novavax COVID-19 Vaccine Candidate 96.4% Effective In U.K. Trial, Company Says

Novavax announced Thursday its vaccine candidate proved to be 96.4% effective against mild, moderate and severe cases of COVID-19 in a Phase 3 trial in the United Kingdom.


You Might Like

Related news from verified sources

After US rebuke, AstraZeneca releases new vaccine data

AstraZeneca reiterated on Wednesday that its Covid-19 vaccine was very effective at preventing the...
IndiaTimes - Published


Related videos from verified sources

Pfizer Says COVID-19 Vaccine Effective In Adolescents [Video]

Pfizer Says COVID-19 Vaccine Effective In Adolescents

The company says clinical trial results showed 100% efficacy in children ages 12 to 15.

Credit: CBS 3 Philly     Duration: 00:24Published
Pfizer And BioNTech Says Its Covid-19 Vaccine Is 100% Effective And Well Tolerated In Children Ages 12 To 15 [Video]

Pfizer And BioNTech Says Its Covid-19 Vaccine Is 100% Effective And Well Tolerated In Children Ages 12 To 15

Clinical trial results of Pfizer/BioNTech's Covid-19 vaccine showed its efficacy is 100% and it is well tolerated in youths ages 12 to 15, the companies said Wednesday.

Credit: WJZ Baltimore     Duration: 00:36Published
Pfizer Covid-19 jab ‘100% effective’ in younger teenagers, research suggests [Video]

Pfizer Covid-19 jab ‘100% effective’ in younger teenagers, research suggests

The Pfizer Covid-19 jab is “100% effective and well tolerated” among children aged 12 to 15, a new study suggests.

Credit: PA - Press Association STUDIO     Duration: 01:00Published